Nanobiotix Shares Fall 4% in Late Afternoon Trading After a 854% Yearly Increase

Monthly and Annual Performance Overview

NANOBIOTIX displays a monthly performance of 27.79%, a level significantly above the 20% alert threshold considered as a signal of abnormal variation. This bullish momentum is part of a particularly strong underlying trend, illustrated by an annual gain of 854.9%. However, over the past week, the stock has lost 15.97%, indicating a phase of consolidation after a recent peak. The market context remains generally favorable this Tuesday, with the CAC 40 up 0.88% at 8,006.12 points and the SBF 120 advancing 0.89%, but this was not enough to support the stock. The VIX volatility index, measuring tension on the American markets, remains at 27.19, a level reflecting persistent nervousness that could amplify movements in high-beta stocks like biotechs, although NANOBIOTIX's beta is measured at 0.43.

Technical Analysis and Market Position

From a graphical perspective, the stock is significantly above its 50-day (€21.56) and 200-day (€14.26) moving averages, confirming that the long-term trend remains upward despite the recent weekly correction. The gap between the current price and these reference levels demonstrates the magnitude of the movement accumulated over several months. The RSI stands at 68, close to the overbought threshold set at 70, indicating that the buying momentum remains active but is approaching a zone of technical tension. The identified resistance at €33.50 is the next key level to watch, while the support at €17.78 remains far from the current prices, illustrating the distance covered from the lows. The monthly implied volatility, at 27.69, reflects the amplitude of recent characteristic oscillations of the stock.